Fig. 8From: Synthesis, crystal structural description, DNA binding, molecular docking, and anticancer evaluation of the novel platinum(IV) supramolecular complexViability percentage of HepG2, HCT116, MDAmb231, and normal cells (MRC5) treated with SC 1Back to article page